To cite this paper use one of the standards below:
The emergence and spread of drug resistance to current antimalarial therapies remains a pressing concern, increasing the need for compounds that demonstrate new modes of action. Brussonol is an icetexane derivative that have been isolated from several terrestrial plants. Recent studies of our group demonstrated that the Brussonol showed inhibitory activities against Plasmodium falciparum in the low micromolar (IC50 = 16 μM) and fast-acting in vitro1. Here, we investigated the mode of action underlying brussonol antiplasmodial activity. A similarity-based search in SciFinder, identified the cyclopiazonic acid (CPA), a highly selective inhibitor for a P. falciparum sarco/endoplasmic reticulum Ca2+-ATPase (PfSERCA) pump2, as structural-related compound to brussonol. Thus, brussonol activity on the calcium modulation was investigated using parasites loaded with intracellular calcium indicator Fluo-4 AM. This investigation indicated that brussonol increased the cytosolic calcium levels within the parasite, however, by a different mechanism than CPA, impacting on calcium homeostasis and parasite development.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper